We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.38B
AUM Growth
+$356M
Cap. Flow
-$95.3M
Cap. Flow %
-1.77%
Top 10 Hldgs %
22.08%
Holding
225
New
6
Increased
74
Reduced
113
Closed
13

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
2
SLB icon
SLB Ltd
SLB
+$19.4M
3
GSK icon
GSK
GSK
+$15.1M
4
EOG icon
EOG Resources
EOG
+$10.5M
5
APA icon
APA Corp
APA
+$9M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$80.1M
2
CELG
Celgene Corp
CELG
+$72.6M
3
BWA icon
BorgWarner
BWA
+$26.4M
4
EXPE icon
Expedia Group
EXPE
+$26.1M
5
XRAY icon
Dentsply Sirona
XRAY
+$19.3M

Sector Composition

Rank Sector Weight
1 Financials 23.04%
2 Technology 14.53%
3 Industrials 13.46%
4 Healthcare 13.02%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
101
CVS Health
CVS
$123B
$6.72M 0.13%
90,514
+86,319
+2,058% +$6.06M
VLO icon
102
Valero Energy
VLO
$87.2B
$6.62M 0.12%
70,695
-5,694
-7% -$538K
LUV icon
103
Southwest Airlines
LUV
$23B
$6.21M 0.12%
115,105
-101,355
-47% -$5.62M
ECL icon
104
Ecolab
ECL
$79.5B
$5.46M 0.1%
28,289
-15,067
-35% -$2.86M
URI icon
105
United Rentals
URI
$72.4B
$5.31M 0.1%
31,830
+271
+0.9% +$39.4K
EXPE icon
106
Expedia Group
EXPE
$36.8B
$4.53M 0.08%
41,917
-222,077
-84% -$26.1M
BRK.B icon
107
Berkshire Hathaway Class B
BRK.B
$1.13T
$4.35M 0.08%
19,196
-700
-4% -$152K
BWA icon
108
BorgWarner
BWA
$13.4B
$3.9M 0.07%
102,066
-719,799
-88% -$26.4M
PG icon
109
Procter & Gamble
PG
$342B
$3.64M 0.07%
29,130
-391
-1% -$47.8K
ELAN icon
110
Elanco Animal Health
ELAN
$12.1B
$3.55M 0.07%
+120,472
New +$3.27M
AMZN icon
111
Amazon
AMZN
$2.94T
$3.54M 0.07%
38,360
-940
-2% -$83.2K
ALC icon
112
Alcon
ALC
$33.9B
$3.13M 0.06%
55,258
-2,642
-5% -$151K
MLM icon
113
Martin Marietta Materials
MLM
$32.3B
$3.1M 0.06%
11,069
-15
-0.1% -$4K
XOM icon
114
ExxonMobil
XOM
$642B
$2.98M 0.06%
42,703
-3,321
-7% -$230K
VFC icon
115
VF Corp
VFC
$5.8B
$2.75M 0.05%
27,562
-22,070
-44% -$1.98M
VZ icon
116
Verizon
VZ
$195B
$2.52M 0.05%
41,095
-115
-0.3% -$6.94K
HD icon
117
Home Depot
HD
$349B
$2.47M 0.05%
11,326
-46
-0.4% -$10.4K
UN
118
DELISTED
Unilever NV New York Registry Shares
UN
$2.41M 0.04%
41,894
-1,410
-3% -$83.3K
APD icon
119
Air Products & Chemicals
APD
$66.8B
$2.39M 0.04%
10,177
-322
-3% -$72.7K
ADBE icon
120
Adobe
ADBE
$103B
$2.38M 0.04%
7,210
-1,169
-14% -$344K
PFE icon
121
Pfizer
PFE
$149B
$2.37M 0.04%
63,864
-2,246
-3% -$80K
BMY.RT
122
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2.15M 0.04%
+714,692
New +$1.86M
WBD icon
123
Warner Bros
WBD
$66.2B
$2.12M 0.04%
64,641
+1,625
+3% +$49K
ZTS icon
124
Zoetis
ZTS
$32.4B
$2.11M 0.04%
15,960
-2,180
-12% -$271K
SBUX icon
125
Starbucks
SBUX
$120B
$2.07M 0.04%
23,515
-804
-3% -$68.6K
3 4
5
6 7

Similar funds

BIM
Bridges Investment Management Omaha, Nebraska $7.38B AUM 15.39% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Douglas Lane & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Douglas Lane & Associates held 225 positions worth $5.38B, up 7.1% from $5.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q4 2019 filing shows 6 new, 74 increased, 113 reduced and 13 closed positions. Its largest new stake was Elanco Animal Health: 120,472 shares worth $3.55M. The largest sale was People Inc, an estimated $80.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Douglas Lane & Associates's largest Q4 2019 buy was Elanco Animal Health: 120,472 shares worth $3.55M.
  • Douglas Lane & Associates added most to Bristol-Myers Squibb in Q4 2019, an estimated $41.5M increase.
  • Douglas Lane & Associates's biggest Q4 2019 reduction was People Inc, cutting an estimated $80.1M.
  • Douglas Lane & Associates fully exited Celgene Corp in Q4 2019, selling an estimated $72.6M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $5.38B portfolio in Q4 2019.
  • Douglas Lane & Associates opened 6 new positions and closed 13 in Q4 2019.
  • Douglas Lane & Associates's portfolio value rose 7.1% quarter-over-quarter to $5.38B.

Based on Douglas Lane & Associates's 13F filing for Q4 2019, filed 27 Jan 2020.